Developer docs
API playgroundTry for free, no card

Search company profiles

Omega Laboratories

Full company profile

uuid0009swm

Namestring
Omega Laboratories
Legal namestring
Omega Laboratories, Inc.
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Omega Laboratories, Inc. is a private biotechnology company founded in 1999 and headquartered in Mogadore, Ohio, with a secondary laboratory in Ontario, Canada. The company provides laboratory-based drug and alcohol testing services across four specimen matrices: hair (90-day detection window via ELISA screening with GC/MS/MS or LC/MS/MS confirmation), oral fluid (using Abbott's Quantisal collection devices), breath (THC detection via the Cannabix Breath Collection Unit with LC-MS/MS analysis), and point-of-care instant testing. Its core technology stack combines a proprietary hair wash method, validated LC-MS/MS breath methodology, and a software platform consisting of the SAMHSA-accredited oCCF custody-and-control system, an Extranet reporting portal, a Test Request Portal, and a SaaS LIMS for toxicology labs, with multi-language support spanning 16 languages.

Omega serves over 6,000 corporate, government, and court-based clients globally, with anchor references including Class I railroad operators (over 50% utilization), Fortune 500 employers, C.R. England, Gordon Trucking, federal agencies operating under DOT, energy, and armed services mandates, and law enforcement/court systems. The business model combines per-specimen laboratory testing fees (quote-based pricing by panel and matrix), recurring SaaS revenue from oCCF and LIMS licensing, and hardware sales of breath collection devices through Cannabix and authorized resellers. Distribution is split between direct enterprise sales to large safety-sensitive employers, a global TPA network managing collection sites, and technology partnerships with Abbott (collection hardware) and AlcoPro (distribution). Omega is the first domestic drug screening organization to earn ISO/IEC 17025 accreditation, holds CAP accreditation for forensic hair testing (one of two labs worldwide), FDA 510(k) clearances across multiple drug panels (one of three labs), CLIA certification, and SAMHSA accreditation for its oCCF system.

Short descriptiontext

Omega Laboratories is a private biotech founded in 1999 that provides laboratory-based drug and alcohol testing across hair, oral fluid, breath, and urine specimens for over 6,000 corporate, government, and court clients worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMogadore, United States
HQ citystring
Mogadore
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
forensic drug testing, hair drug testing, oral fluid testing, breath THC testing, toxicology laboratory services
Industry3 codes
PRIMARYHLAFAMAF
Toxicology & Therapeutic Drug Monitoring Laboratories
SECONDARYHLAFAMAB
Clinical Chemistry & Immunoassay Laboratories
SECONDARYHLAFAMAK
Occupational Health & Employer Testing Laboratories
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Forensic Toxicology Laboratory Services
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Laboratory Testing Services
TypeSubscription Recurring
Description

Omega provides laboratory-based testing services for hair, oral fluid, and breath specimens. Testing is performed using ELISA screening followed by GC/MS/MS or LC/MS/MS confirmation. Revenue is generated per test based on panel type and specimen matrix.

omegalaboratories.com
2Software/SaaS Products
TypeSubscription Recurring
Description

Omega generates revenue from its oCCF (Online Custody and Control Form) system and LIMS software. These products are offered as SaaS solutions, some under license or subscription agreements to third-party firms.

3Breath Collection Devices
TypeHardware Sales
Description

Revenue from sale of Cannabix Breath Collection Units and disposable breath cartridges. Omega provides laboratory analysis services while Cannabix provides the hardware. First commercial sales were made in March 2026 through authorized resellers.

omegalaboratories.com
4Instant Testing Products
TypeOne Time License
Description

Sale of instant oral fluid and urine drug screening kits in 4-10 panel configurations. Products include F.S.D. Cup for oral fluid and instant urine screens with GC/MS laboratory confirmation available.

omegalaboratories.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Laboratory-based testing services by specimen type
ModelOtherBilling cadencePay-as-you-go
Notes

Pricing varies by specimen type (hair, oral fluid, breath), panel configuration (number of drug classes tested), and testing methodology. Volume discounts may apply for larger clients. oCCF system is free for Omega clients performing laboratory-based hair and oral fluid testing.

omegalaboratories.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Omega Laboratories provides laboratory-based forensic drug and alcohol testing services across hair, oral fluid, breath, and urine specimens using ELISA screening combined with mass spectrometry (GC/MS/MS and LC/MS/MS) confirmation. The company complements its testing services with the oCCF custody and control platform, the Extranet reporting portal, and a SaaS LIMS for toxicology laboratories, and partners with Cannabix Technologies for hardware and Abbott for Quantisal oral fluid collection devices.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 5-15x more drug users detected compared to laboratory-based urine testing programs
+4 more records
Product overview1 text field

Omega Laboratories provides a comprehensive suite of drug and alcohol testing solutions centered around laboratory analysis of multiple specimen types. The core offering consists of four primary testing methods: Breath Testing (THC detection using Cannabix BCU with LC-MS/MS), Hair Testing (90-day detection window using ELISA screening with GC/MS/MS or LC/MS/MS confirmation), Oral Fluid Testing (using Abbott's Quantisal devices), and Instant Testing (point-of-care devices with laboratory confirmation). These testing services are supported by a technology platform including oCCF (Online Custody & Control Form system - SAMHSA-accredited and available in 16+ languages), Extranet reporting portal, Test Request Portal, and LIMS software. Omega was founded in 1999, serves over 6,000 corporate, government, and court-based clients worldwide, and holds ISO/IEC 17025 accreditation as the first domestic drug screening organization. The company operates from facilities in Mogadore, Ohio (headquarters with 44,000+ sq ft) and Ontario, Canada.

Product and service7 records
1Hair Testing
CategoryForensic Laboratory Testing Services
Description

Laboratory-based hair drug testing analyzing head or body hair specimens for drugs of abuse using ELISA screening followed by GC/MS/MS or LC/MS/MS confirmation. Provides approximately 90 days of drug use history using 1.5 inches of head hair and is intended for employers, courts, and government programs requiring forensically defensible historical use data.

2Oral Fluid Testing
CategoryForensic Laboratory Testing Services
Description

Laboratory-based oral fluid drug testing using Abbott Quantisal I and Quantisal II collection devices. Detects drug use within approximately 30–60 minutes of ingestion with a 24–48 hour detection window, intended for employers and other clients needing short-window, non-invasive specimen collection.

3Breath Testing
CategoryForensic Laboratory Testing Services
Description

Marijuana breath testing using the Cannabix Breath Collection Unit combined with Omega's LC-MS/MS laboratory analysis. Detects recent cannabis consumption within approximately 4 hours and offers a non-invasive alternative to urine, blood, and oral fluid for workplace safety and law enforcement applications.

4Instant Testing
CategoryPoint-of-Care Testing Products
Description

Point-of-care instant oral fluid and urine drug screening devices sold in 4–10 panel configurations, including the F.S.D. Cup and instant urine screens, with optional GC/MS laboratory confirmation. Designed for employers and collection sites needing rapid on-site preliminary results.

5Omega Hair 17-Panel Drug Test
CategoryForensic Laboratory Testing Services
Description

Comprehensive hair drug test panel detecting 45 substances across major drug classes including Amphetamines, Cocaine, Marijuana, Opiates, Synthetic Opiates, Fentanyl, Benzodiazepines, Barbiturates, Methadone, Tramadol, and Ketamine. Sold to employers and other clients needing the broadest hair-based detection coverage available from the company.

6oCCF (Online Custody & Control Form)
CategorySaaS Compliance Platform
Description

SaaS-delivered web-based Custody and Control Form system providing data collection and reporting for laboratory-based and point-of-collection drug testing, available in 16 languages and SAMHSA-accredited for federally regulated testing. Free to use for Omega's laboratory clients performing hair and oral fluid testing; licensed to other employers, TPAs, and clinics.

7LIMS (Laboratory Information Management System)
CategorySaaS Laboratory Software
Description

Laboratory Information Management System designed specifically for toxicology laboratories and offered as a SaaS solution to other laboratories needing local service capabilities, with integration into Omega's oCCF and Extranet platforms. Developed and delivered through the Omega Technology Solutions subsidiary.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-05-16
Description

Strategic partnership established in May 2024 for marijuana breath testing. Omega serves as exclusive laboratory services provider for Cannabix's Marijuana Breath Test (MBT) system. Partnership includes co-development of breath collection technology and analytical methods. Validated methodology published in Journal of Analytical Toxicology in March 2026. First commercial sales achieved in March 2026 targeting safety-sensitive industries including construction, transportation, and manufacturing.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-10-04
Description

Acquired in October 2022, Acumium is a Madison, Wisconsin-based technology and software development firm with 21 years of experience. Previously collaborated with Omega for over 15 years on systems including oCCF and LIMS. Integration created Omega Technology Solutions, combining laboratory expertise with software development capabilities.

3Abbott (Quantisal)
Strategic tierCoreTypeTechnology or Integration
Description

Partnership with Abbott for oral fluid collections via Quantisal I and II devices. Quantisal's oral fluid collection devices provide consistent validation for specimen collection. Dual device (Quantisal II) will be required for future SAMHSA/DOT oral fluid testing.

omegalaboratories.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Partnership with AlcoPro for distribution of marijuana breath testing products. AlcoPro serves as a distribution channel for the Cannabix-Omega breath testing system.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Developer of a portable THC breathalyzer for workplace and law enforcement impairment detection. Competes with the Cannabix/Omega breath-testing workflow at the device layer, though Hound Labs focuses on point-of-use hardware rather than laboratory analysis.

TypeDirect peer
Description

Pioneer and one of the most established hair drug testing laboratories in the US, with comparable ELISA screening and GC/MS/MS confirmation methodology. Direct head-to-head competitor for the same pre-employment and workplace hair testing customers Omega targets.

TypeBroad incumbent
Description

Largest US clinical laboratory with a workplace drug testing franchise including urine, oral fluid, and hair testing. Significantly broader test menu and national footprint; competes with Omega on enterprise employer and government contracts but is not specialized in alternative specimens.

TypeDirect peer
Description

Mid-sized clinical and forensic toxicology laboratory offering workplace drug testing, including urine, hair, and oral fluid specimen analysis. Comparable employer and government client base with similar regulatory certifications.

TypeDirect peer
Description

Specialty toxicology laboratory focused on urine drug testing, oral fluid testing, and pharmacogenetic testing serving physicians, pain management, and substance use disorder treatment. Comparable toxicology menu and customer overlap in regulated testing.

TypeDirect peer
Description

Specialty forensic toxicology lab offering urine, oral fluid, and hair testing to clinicians, employers, and the legal system. Comparable toxicology focus, multi-matrix approach, and court-admissible testing services.

TypeDirect peer
Description

Specialty toxicology laboratory offering urine drug testing and oral fluid testing for pain management, substance use disorder treatment, and workplace monitoring. Comparable menu and customer overlap in regulated testing.

TypeBroad incumbent
Description

Major clinical laboratory network with a substantial employer and forensic drug testing business, including urine and oral fluid screening. Competes with Omega on enterprise and government programs but does not focus on alternative-specimen testing.

TypeEmerging player
Description

Provider of touch-based alcohol and biometric screening devices for workplace safety and behavioral health. Adjacent competitor in the impairment-detection category relevant to Omega's THC breath testing growth thesis.

TypeDirect peer
Description

Specialty toxicology lab providing urine, oral fluid, and hair drug testing for pain management, behavioral health, and workplace monitoring. Directly comparable multi-matrix toxicology offering and channel into regulated employer programs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance11 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Omega Laboratories

Forensic Toxicology Laboratory Servicesomegalaboratories.com

Omega Laboratories is a private biotech founded in 1999 that provides laboratory-based drug and alcohol testing across hair, oral fluid, breath, and urine specimens for over 6,000 corporate, government, and court clients worldwide.

What Omega Laboratories does

Omega Laboratories, Inc. is a private biotechnology company founded in 1999 and headquartered in Mogadore, Ohio, with a secondary laboratory in Ontario, Canada. The company provides laboratory-based drug and alcohol testing services across four specimen matrices: hair (90-day detection window via ELISA screening with GC/MS/MS or LC/MS/MS confirmation), oral fluid (using Abbott's Quantisal collection devices), breath (THC detection via the Cannabix Breath Collection Unit with LC-MS/MS analysis), and point-of-care instant testing. Its core technology stack combines a proprietary hair wash method, validated LC-MS/MS breath methodology, and a software platform consisting of the SAMHSA-accredited oCCF custody-and-control system, an Extranet reporting portal, a Test Request Portal, and a SaaS LIMS for toxicology labs, with multi-language support spanning 16 languages.

Omega serves over 6,000 corporate, government, and court-based clients globally, with anchor references including Class I railroad operators (over 50% utilization), Fortune 500 employers, C.R. England, Gordon Trucking, federal agencies operating under DOT, energy, and armed services mandates, and law enforcement/court systems. The business model combines per-specimen laboratory testing fees (quote-based pricing by panel and matrix), recurring SaaS revenue from oCCF and LIMS licensing, and hardware sales of breath collection devices through Cannabix and authorized resellers. Distribution is split between direct enterprise sales to large safety-sensitive employers, a global TPA network managing collection sites, and technology partnerships with Abbott (collection hardware) and AlcoPro (distribution). Omega is the first domestic drug screening organization to earn ISO/IEC 17025 accreditation, holds CAP accreditation for forensic hair testing (one of two labs worldwide), FDA 510(k) clearances across multiple drug panels (one of three labs), CLIA certification, and SAMHSA accreditation for its oCCF system.

Omega Laboratories firmographics

Firmographics
Name
Omega Laboratories
Legal name
Omega Laboratories, Inc.
Website
https://omegalaboratories.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
51–100 employees
Short description
Omega Laboratories is a private biotech founded in 1999 that provides laboratory-based drug and alcohol testing across hair, oral fluid, breath, and urine specimens for over 6,000 corporate, government, and court clients worldwide.
Ownership category
akta.pro rank

Omega Laboratories industry classification

Industry
Product category
Forensic Toxicology Laboratory Services
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAFAMAF
Toxicology & Therapeutic Drug Monitoring Laboratories
SECONDARYHLAFAMAB
Clinical Chemistry & Immunoassay Laboratories
SECONDARYHLAFAMAK
Occupational Health & Employer Testing Laboratories

Keywords

  • Forensic drug testing
  • Hair drug testing
  • Oral fluid testing
  • Breath THC testing
  • Toxicology laboratory services

Where Omega Laboratories is headquartered

Location

Headquarters

HQ city
Mogadore
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Omega Laboratories business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Laboratory Testing Services: Omega provides laboratory-based testing services for hair, oral fluid, and breath specimens. Testing is performed using ELISA screening followed by GC/MS/MS or LC/MS/MS confirmation. Revenue is generated per test based on panel type and specimen matrix.
  2. Software/SaaS Products: Omega generates revenue from its oCCF (Online Custody and Control Form) system and LIMS software. These products are offered as SaaS solutions, some under license or subscription agreements to third-party firms.
  3. Breath Collection Devices: Revenue from sale of Cannabix Breath Collection Units and disposable breath cartridges. Omega provides laboratory analysis services while Cannabix provides the hardware. First commercial sales were made in March 2026 through authorized resellers.
  4. Instant Testing Products: Sale of instant oral fluid and urine drug screening kits in 4-10 panel configurations. Products include F.S.D. Cup for oral fluid and instant urine screens with GC/MS laboratory confirmation available.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goLaboratory-based testing services by specimen type

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Omega Laboratories product offering

Product offering

Core offering

Omega Laboratories provides laboratory-based forensic drug and alcohol testing services across hair, oral fluid, breath, and urine specimens using ELISA screening combined with mass spectrometry (GC/MS/MS and LC/MS/MS) confirmation. The company complements its testing services with the oCCF custody and control platform, the Extranet reporting portal, and a SaaS LIMS for toxicology laboratories, and partners with Cannabix Technologies for hardware and Abbott for Quantisal oral fluid collection devices.

Product overview

Omega Laboratories provides a comprehensive suite of drug and alcohol testing solutions centered around laboratory analysis of multiple specimen types. The core offering consists of four primary testing methods: Breath Testing (THC detection using Cannabix BCU with LC-MS/MS), Hair Testing (90-day detection window using ELISA screening with GC/MS/MS or LC/MS/MS confirmation), Oral Fluid Testing (using Abbott's Quantisal devices), and Instant Testing (point-of-care devices with laboratory confirmation). These testing services are supported by a technology platform including oCCF (Online Custody & Control Form system - SAMHSA-accredited and available in 16+ languages), Extranet reporting portal, Test Request Portal, and LIMS software. Omega was founded in 1999, serves over 6,000 corporate, government, and court-based clients worldwide, and holds ISO/IEC 17025 accreditation as the first domestic drug screening organization. The company operates from facilities in Mogadore, Ohio (headquarters with 44,000+ sq ft) and Ontario, Canada.

Differentiator

Problem solved

Functional benefit

Products and services

  • Hair Testing Laboratory-based hair drug testing analyzing head or body hair specimens for drugs of abuse using ELISA screening followed by GC/MS/MS or LC/MS/MS confirmation. Provides approximately 90 days of drug use history using 1.5 inches of head hair and is intended for employers, courts, and government programs requiring forensically defensible historical use data.
  • Oral Fluid Testing Laboratory-based oral fluid drug testing using Abbott Quantisal I and Quantisal II collection devices. Detects drug use within approximately 30–60 minutes of ingestion with a 24–48 hour detection window, intended for employers and other clients needing short-window, non-invasive specimen collection.
  • Breath Testing Marijuana breath testing using the Cannabix Breath Collection Unit combined with Omega's LC-MS/MS laboratory analysis. Detects recent cannabis consumption within approximately 4 hours and offers a non-invasive alternative to urine, blood, and oral fluid for workplace safety and law enforcement applications.
  • Instant Testing Point-of-care instant oral fluid and urine drug screening devices sold in 4–10 panel configurations, including the F.S.D. Cup and instant urine screens, with optional GC/MS laboratory confirmation. Designed for employers and collection sites needing rapid on-site preliminary results.
  • Omega Hair 17-Panel Drug Test Comprehensive hair drug test panel detecting 45 substances across major drug classes including Amphetamines, Cocaine, Marijuana, Opiates, Synthetic Opiates, Fentanyl, Benzodiazepines, Barbiturates, Methadone, Tramadol, and Ketamine. Sold to employers and other clients needing the broadest hair-based detection coverage available from the company.
  • oCCF (Online Custody & Control Form) SaaS-delivered web-based Custody and Control Form system providing data collection and reporting for laboratory-based and point-of-collection drug testing, available in 16 languages and SAMHSA-accredited for federally regulated testing. Free to use for Omega's laboratory clients performing hair and oral fluid testing; licensed to other employers, TPAs, and clinics.
  • LIMS (Laboratory Information Management System) Laboratory Information Management System designed specifically for toxicology laboratories and offered as a SaaS solution to other laboratories needing local service capabilities, with integration into Omega's oCCF and Extranet platforms. Developed and delivered through the Omega Technology Solutions subsidiary.

Quantifiable outcome

  • 5-15x more drug users detected compared to laboratory-based urine testing programs
  • +4 more outcomes

Companies that use Omega Laboratories

Customer profile

Named customers6 records

Segments5 records

Ideal customer profiles3 records

Omega Laboratories technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature6 records

Omega Laboratories partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Cannabix Technologies Inc.coreStrategic or Co-development Partner · 16 May 2024Strategic partnership established in May 2024 for marijuana breath testing. Omega serves as exclusive laboratory services provider for Cannabix's Marijuana Breath Test (MBT) system. Partnership includes co-development of breath collection technology and analytical methods. Validated methodology published in Journal of Analytical Toxicology in March 2026. First commercial sales achieved in March 2026 targeting safety-sensitive industries including construction, transportation, and manufacturing.
  • AcumiumcoreTechnology or Integration · 4 October 2022Acquired in October 2022, Acumium is a Madison, Wisconsin-based technology and software development firm with 21 years of experience. Previously collaborated with Omega for over 15 years on systems including oCCF and LIMS. Integration created Omega Technology Solutions, combining laboratory expertise with software development capabilities.
  • Abbott (Quantisal)coreTechnology or IntegrationPartnership with Abbott for oral fluid collections via Quantisal I and II devices. Quantisal's oral fluid collection devices provide consistent validation for specimen collection. Dual device (Quantisal II) will be required for future SAMHSA/DOT oral fluid testing.
  • AlcoProminorChannel Partner/ Reseller/ DistributorPartnership with AlcoPro for distribution of marijuana breath testing products. AlcoPro serves as a distribution channel for the Cannabix-Omega breath testing system.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Omega Laboratories competitors and assessment

Company assessment

Emerging players

  • Hound Labs: Developer of a portable THC breathalyzer for workplace and law enforcement impairment detection. Competes with the Cannabix/Omega breath-testing workflow at the device layer, though Hound Labs focuses on point-of-use hardware rather than laboratory analysis.
  • SOBR Safe: Provider of touch-based alcohol and biometric screening devices for workplace safety and behavioral health. Adjacent competitor in the impairment-detection category relevant to Omega's THC breath testing growth thesis.

Direct peers

  • Psychemedics Corporation: Pioneer and one of the most established hair drug testing laboratories in the US, with comparable ELISA screening and GC/MS/MS confirmation methodology. Direct head-to-head competitor for the same pre-employment and workplace hair testing customers Omega targets.
  • Clinical Reference Laboratory (CRL): Mid-sized clinical and forensic toxicology laboratory offering workplace drug testing, including urine, hair, and oral fluid specimen analysis. Comparable employer and government client base with similar regulatory certifications.
  • Millennium Health: Specialty toxicology laboratory focused on urine drug testing, oral fluid testing, and pharmacogenetic testing serving physicians, pain management, and substance use disorder treatment. Comparable toxicology menu and customer overlap in regulated testing.
  • Aegis Sciences Corporation: Specialty forensic toxicology lab offering urine, oral fluid, and hair testing to clinicians, employers, and the legal system. Comparable toxicology focus, multi-matrix approach, and court-admissible testing services.
  • Dominion Diagnostics: Specialty toxicology laboratory offering urine drug testing and oral fluid testing for pain management, substance use disorder treatment, and workplace monitoring. Comparable menu and customer overlap in regulated testing.
  • Cordant Health Solutions: Specialty toxicology lab providing urine, oral fluid, and hair drug testing for pain management, behavioral health, and workplace monitoring. Directly comparable multi-matrix toxicology offering and channel into regulated employer programs.

Broad incumbents

  • Quest Diagnostics: Largest US clinical laboratory with a workplace drug testing franchise including urine, oral fluid, and hair testing. Significantly broader test menu and national footprint; competes with Omega on enterprise employer and government contracts but is not specialized in alternative specimens.
  • Laboratory Corporation of America (Labcorp): Major clinical laboratory network with a substantial employer and forensic drug testing business, including urine and oral fluid screening. Competes with Omega on enterprise and government programs but does not focus on alternative-specimen testing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Omega Laboratories social profiles

Digital presence

Omega Laboratories compliance and trust

Trust signal

Compliance11 records

Omega Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Omega Laboratories leadership team

Management profile

Number of profiles

Profiles5 records

Omega Laboratories subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Omega Laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Omega Laboratories M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Omega Laboratories

What does Omega Laboratories do?

Omega Laboratories provides laboratory-based forensic drug and alcohol testing services across hair, oral fluid, breath, and urine specimens using ELISA screening combined with mass spectrometry (GC/MS/MS and LC/MS/MS) confirmation. The company complements its testing services with the oCCF custody and control platform, the Extranet reporting portal, and a SaaS LIMS for toxicology laboratories, and partners with Cannabix Technologies for hardware and Abbott for Quantisal oral fluid collection devices.

Is Omega Laboratories a public or private company?

Omega Laboratories is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Omega Laboratories founded?

Omega Laboratories was founded in 1999. It employs 51 to 100 people.

Where is Omega Laboratories based?

Omega Laboratories is headquartered in Mogadore, United States, in the North America region.

How does Omega Laboratories make money?

Four revenue lines are on record. Laboratory Testing Services are the primary driver. The others are software/SaaS Products, breath Collection Devices and instant Testing Products.

Who are Omega Laboratories's main competitors?

Emerging players on record are Hound Labs and SOBR Safe. Direct peers are Psychemedics Corporation, Clinical Reference Laboratory (CRL), Millennium Health, Aegis Sciences Corporation, Dominion Diagnostics and Cordant Health Solutions. Broad incumbents are Quest Diagnostics and Laboratory Corporation of America (Labcorp).

Does Omega Laboratories have an API?

No public API is recorded for Omega Laboratories.

What industry is Omega Laboratories in?

Omega Laboratories's product category is Forensic Toxicology Laboratory Services. Its primary akta.pro industry code is HLAFAMAF, Toxicology & Therapeutic Drug Monitoring Laboratories, with a secondary code of HLAFAMAB, Clinical Chemistry & Immunoassay Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Marijuana MomentBoxing And Combat Sports Officials Consider Marijuana Breathalyzer Device For FightersCannabix Technologies Inc. is presenting its marijuana breath testing device at the Association of Boxing Commissions and Combative Sports annual conference in Orlando, Florida, pitching it to combat sports regulators and athletic commissions as a tool to detect recent cannabis use closer to competition time. Unlike traditional specimen testing, the device is designed to identify impairment near the time of athletic performance rather than detecting use long after effects have subsided. The company is partnering with Omega Laboratories for the presentation as it seeks to expand into the combat sports regulatory market amid evolving state cannabis laws.GlobeNewswireCannabix Targets Combat Sports Market for Commercial Rollout of Marijuana Breath Test at ABC Boxing & MMA ConferenceCannabix Technologies will present its Marijuana Breath Test at the ABC Boxing & MMA Conference in Orlando in August. The company aims to commercialize the breath-based THC testing for combat sports regulators, with Omega Laboratories providing laboratory confirmation. Cannabix also plans a 5-panel breath testing platform for broader safety-sensitive markets.YahooCannabix Targets Combat Sports Market for Commercial Rollout of Marijuana Breath Test at ABC Boxing & MMA ConferenceCannabix Technologies Inc. announced that its Marijuana Breath Test technology has been invited to present at the Association of Boxing Commissions and Combative Sports 38th Annual Conference in Orlando, Florida, in August 2026. The company, along with its strategic laboratory partner Omega Laboratories, will use this opportunity to demonstrate breath-based THC testing directly to combat sports regulators, athletic commissions, and sanctioning bodies. Cannabix views the combat sports market as a significant commercialization opportunity, positioning its recent-use breath testing as a practical alternative to traditional specimen testing that can detect cannabis long after effects have subsided.GlobeNewswireCannabix Technologies and Omega Laboratories Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use DetectionCannabix Technologies Inc. and Omega Laboratories, Inc. have announced the development and validation of a DOT-like drug testing panel for breath analysis, enabling simultaneous detection of multiple drug classes including amphetamines, cocaine, marijuana, opiates, and PCP in breath aerosols. The validated method expands Omega's existing breath-testing capabilities beyond THC detection, using mass spectrometry for confirmatory analysis with a detection window of minutes to hours after use. The companies expect this technology to address demand from employers, law enforcement, courts, and other safety-sensitive environments seeking more time-relevant drug detection compared to traditional urine, oral fluid, or hair testing matrices.Stock TitanOmega, Cannabix validate breath drug test panelOmega Laboratories and Cannabix Technologies announced the development and validation of a DOT-like multi-drug breath test panel that detects amphetamines, methamphetamines, cocaine, marijuana, opiates, and PCP, expanding beyond Omega's existing THC breath-testing capability. The validated laboratory method uses mass spectrometry and Cannabix's Breath Collection Unit to provide recent-use detection measured in minutes to hours rather than days or months, targeting employers, courts, criminal justice programs, and other safety-sensitive environments. The companies expect breath testing to complement existing drug-testing matrices as demand grows for time-relevant, scientifically defensible testing options amid expanding marijuana legalization.NewswireOmega Laboratories and Cannabix Technologies Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use DetectionOmega Laboratories and Cannabix Technologies announced a validated breath-testing panel modeled after the DOT urine drug test, covering amphetamines, cocaine, marijuana, opiates, and PCP. The laboratory-based method uses mass spectrometry and is available to existing and new clients. The company expects breath testing to complement existing drug-testing matrices for recent-use detection.MorningstarOmega Laboratories and Cannabix Technologies Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use DetectionOmega Laboratories and Cannabix Technologies announced a validated breath-testing panel modeled after the DOT urine drug test, covering amphetamines, cocaine, marijuana, opiates, and PCP. The method uses mass spectrometry and the Cannabix Breath Collection Unit to detect recent use within minutes to hours. The company expects breath testing to complement existing drug-testing matrices in safety-sensitive settings.PR NewswireOmega Laboratories and Cannabix Technologies Announce Breath-Based DOT-Like Drug Testing Panel for Recent-Use DetectionOmega Laboratories and Cannabix Technologies announced a validated breath-testing panel modeled after the DOT urine drug test, covering amphetamines, cocaine, marijuana, opiates, and PCP. The method uses mass spectrometry and is designed for recent-use detection in safety-sensitive settings. The company expects breath testing to complement existing testing matrices.Stock TitanCannabix detects cocaine in breath samplesCannabix Technologies announced that its Marijuana Breath Test (MBT) system successfully detected cocaine and its primary metabolite benzoylecgonine in human breath samples collected using the company's Breath Collection Unit and analyzed by Omega Laboratories using liquid chromatography-mass spectrometry. The company stated this breakthrough demonstrates the technology's capability to extend beyond THC detection into broader multi-drug breath testing applications for workplace safety, transportation, and law enforcement markets. CEO Rav Mlait noted that detecting these compounds is technically challenging due to their extremely low concentrations in breath.Stock TitanCannabix detects methamphetamine, amphetamine in breathCannabix Technologies Inc. announced that its Marijuana Breath Test (MBT) successfully detected methamphetamine and amphetamine compounds in human breath samples collected using the Cannabix Breath Collection Unit and analyzed by Omega Laboratories Inc. using liquid chromatography-mass spectrometry. The detection of amphetamine-class stimulants—present at extremely low concentrations in breath—validates the sensitivity and performance of the company's breath testing technology beyond its original THC focus. The company stated these early findings support potential expansion of the MBT into workplace safety, transportation, industrial, and law enforcement markets seeking non-invasive, scientifically defensible drug testing solutions.